Accuitis
PrivateLast Round
VC Round
Nov 23, 2015
Company Overview
Accuitis is a pharmaceutical company that develops small molecule compounds validated in preclinical models for neurodegenerative, age-related, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accuitis Comparables
Compare Accuitis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mitochon Pharmaceuticals | 81% | |
| NRG Therapeutics | 79% | |
| Vandria | 77% |
Accuitis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 23, 2015 | ||||
| VC Round | Mar 23, 2015 |
Accuitis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Georgia Research Alliance | VC Round |
| Bio/Med Investor Network | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 23, 2015
$1M raised from Bio/Med Investor Network and Georgia Research Alliance.
- Mar 23, 2015
$495K raised from Bio/Med Investor Network and GRA.
Accuitis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Accuitis's valuation, stock price, and market status.
Is Accuitis a public or private company?
Accuitis is a private company.
What is the current stock price of Accuitis?
Accuitis is a private company with no public stock price. No recent secondary market data is available.
How much is Accuitis worth (valuation)?
Valuation information for Accuitis is not publicly available.
Can I buy Accuitis stock?
Accuitis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Accuitis's last funding round?
Accuitis's most recent funding round was VC Round on November 23, 2015.
Who are the main investors in Accuitis?
Key investors in Accuitis include Bio/Med Investor Network.
Will Accuitis IPO soon?
No public IPO plans have been announced for Accuitis.
How can I track Accuitis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Accuitis's secondary market activity and sign up for updates.